TrialBone marrow transplantation2025

Impact of cytopenias and early versus late treatment with ruxolitinib in patients with steroid-refractory acute or chronic graft-versus-host disease.

Zahra Mahmoudjafari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.